Impact of organochlorine pollutants on child development in Guadeloupe
Official title: Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe
Run by Centre Hospitalier Universitaire de la Guadeloupe · NCT06653660 · Data updated 2026-11-12
This study looks at how exposure to a harmful insecticide affects the growth and development of children in Guadeloupe as they reach puberty.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 22 Years |
| Sex | All |
| Enrollment | 650 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de la Guadeloupe Academic / other |
| Locations | 1 site (Pointe-à-Pitre, Guadeloupe) |
| Status | Recruiting |
| Started | December 19, 2022 |
| Main results expected | December 19, 2026 |
| Study ends | December 19, 2026 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT06653660 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children born to mothers who participated in the TIMOUN cohort and are currently residing in Guadeloupe at peripubertal age.
✕Probably not a fit
Patients who may not benefit from this study include those whose mothers were not part of the TIMOUN cohort or who do not reside in Guadeloupe.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the effects of chlordecone, an organochlorine insecticide, on the development of children born in Guadeloupe. It focuses on children from the TIMOUN cohort, who are now reaching peripubertal ages, to assess potential health consequences of prenatal and postnatal exposure to this persistent pollutant. The study aims to verify hypotheses regarding the endocrine-disrupting properties of chlordecone and its impact on sexual development and puberty timing. The research is driven by societal concerns and recommendations from health authorities regarding the effects of environmental toxins on children.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the health impacts of environmental pollutants on child development, potentially guiding public health interventions.
How similar studies have gone: Other studies have shown success in assessing the health impacts of environmental pollutants, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be born to a mother whose pregnancy was included in the Timoun cohort (2004 - 2007) and whose parents agreed to be contacted later. * Residing in Guadeloupe at the peripubertal age * Affiliation to a social security scheme * Agreement to participate in the study and informed consent signed by the minor * Study participation agreement and informed consent signed by the parents Exclusion Criteria: * Refusal to participate in the research
Where it's running
-
CHU of Guadeloupe
Pointe-à-Pitre, Guadeloupe, Guadeloupe Recruiting
Study contacts
- Principal investigator: Gulen AYHAN — CHU of Guadeloupe
- Study coordinator: Valérie HAMONY-SOTER
- Email: valerie.soter@chu-guadeloupe.fr
- Phone: +590 590 93 46 77
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.